Safety Considerations for Container Labels and Carton Labeling Design to Minimize Medication Errors
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
May 18, 2022
May 18, 2022
e13010c8-daa7-439e-bd49-fa88d08456a3
Related Documents
Clinical Pharmacology Considerations for Antibody-Drug Conjugates Guidance for Industry: Guidance for Industry
Guidance DocumentMarch 1, 2024Center for Drug Evaluation and Research
General Clinical Pharmacology Considerations for Neonatal Studies for Drugs and Biological Products Guidance for Industry
Guidance DocumentJuly 27, 2022Center for Drug Evaluation and Research
Q12 Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management Annex
Guidance DocumentMay 11, 2021Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.